Navigation Links
Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
Date:10/14/2008

DURHAM, N.C., Oct. 10 /PRNewswire/ -- Regado Biosciences, Inc., announced today the Company has completed enrollment in the Phase IIa clinical study of its REG1 Anticoagulation System in patients undergoing elective percutaneous coronary intervention (PCI). REG1 is a two-component system composed of an aptamer-based anticoagulant, RB006, and its matched, active reversal agent, RB007, which specifically binds to and neutralizes RB006. The Phase IIa study (REVERSAL-PCI) is designed to assess whether REG1 can replace standard heparin therapy during the performance of coronary balloon angioplasty dilatation and stenting on patients at low risk for complications associated with therapy-related bleeding or heart attack.

REVERSAL-PCI, a multi-center, open-label, randomized clinical study, has enrolled a total of 26 patients. All patients were pretreated with clopidogrel and aspirin to inhibit platelet activity and were then randomized to receive either REG1 or unfractionated heparin. In patients treated with the REG1 System, RB006 was used as the sole anticoagulant during the procedure. Following the procedure, RB007 was used to reverse the effects of RB006 with the goal of facilitating early sheath removal. Primary procedural success in the trial is defined by the absence of significant bleeding events up to hospital discharge or 48 hours post stenting, and by the absence of death, nonfatal heart attack, or need to repeat revascularization up to day 14.

David J. Mazzo, Ph.D., President and Chief Executive Officer of Regado Biosciences, stated, "The Phase IIa trial is designed to build on extensive Phase I results demonstrating, among other things, that RB006 safely and effectively inhibited the activity of factor IXa, an essential blood clotting protein, and that RB007 rapidly, safely and specifically reversed the activity of RB006. We are pleased to have reached this milestone in our clinical program and look forward to continued progress in the comi
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
2. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
5. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
6. Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting
7. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
8. Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at American College of Gastroenterology Annual Scientific Meeting
9. Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
10. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
11. Ardea Biosciences Advances Lead Product Candidate for the Treatment of Gout, RDEA594, Into Phase 1 Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Maxim ... ) makes it easy to calibrate ... monitor or control unsanitary reuse of ... nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s gamma ...
(Date:5/27/2015)... , May 27, 2015  Foundation Health Care  (FDNH), ... related ancillary services, announced today it will present at ... 1-3, 2015 at Luxe Sunset Boulevard Hotel, ... on Tuesday, June 2 nd at 3:00pm and ... a one-on-one meeting please contact LD Micro. For more ...
(Date:5/27/2015)... UNION CITY, Calif. , May 27, 2015 /PRNewswire/ ... company manufacturing point-of-care blood analysis systems, announced today that ... and investor relations, transitioning into the role of chief ... the Jefferies 2015 Global Healthcare Conference on Thursday, June ... be held at the Grand Hyatt in ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3
... 19, 2011  The National Urban League (NUL) and the League ... Inc. (ESI) to resume negotiations and come to an agreement ... not reached, millions of Americans, especially in diverse and underserved ... 1, 2012. In an open letter to ...
... Dec. 19, 2011 /PRNewswire-iReach/ --  In an effort ... time and on schedule, Apothecary Shop Wholesale, Inc. ... is distributing a novel medication adherence aid called GlowCap®, ... that reminds patients to take their medication through sound ...
Cached Medicine Technology:The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 2The National Urban League and League of United Latin American Citizens Urge Express Scripts to Reach Agreement with Walgreens 3The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders 2
(Date:5/27/2015)... “Heroin has never been more plentiful or cheaper, or ... says Harford County Sheriff Jeff Gahler, as quoted by the ... heroin related incidents in Baltimore, police resources are running thin. ... addiction and subsequent abuse before it turns into a fatal ... a drug and alcohol rehab facility specializing in heroin rehab. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 For a limited ... Ghasri, is now offering discounts on facial fillers. Skin loses ... the age of 18. This lost collagen can lead to ... wrinkles and expression lines. Facial fillers are an excellent way ... turn to facial fillers to create a softer and more ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 A television ... MediaSource and Roswell Park Cancer Institute ... , The award-winning story, Cancer Can’t Win , ... Roswell Park Cancer Institute. The production team followed five ... several months as they received treatment from doctors and ...
(Date:5/27/2015)... founder of FACE, the award-winning beauty clinic, is detailing several ... the body’s largest organ and is exposed to many environmental ... skin cancer are diagnosed in the United States and over ... , There are several things people can do to ... the hours of 10 AM and 4 PM, when the ...
(Date:5/27/2015)... CT (PRWEB) May 27, 2015 CRN ... John Prinner as its new Chief Financial Officer. , ... Holdings, and prior to that held financial/operational executive positions ... Intensity, Vivaro Corp., Conversent Communications, Utilicom, and SNET. ... at PricewaterhouseCoopers. , At CRN, Prinner will be able ...
Breaking Medicine News(10 mins):Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3Health News:In Recognition of National Melanoma Awareness Month, Beauty Guru Details Skin Tips to Prevent Cancer and Premature Aging 2Health News:CRN International Names New Chief Financial Officer 2
... counsel patients, it is key for clinicians of different ... syndrome, between two medical disorders - ALS and FTD ... new study, Catherine Lomen-Hoerth, from the University of California ... a research perspective, identifying the syndrome early is an ...
... lower quality of care because they typically have fewer staff ... the finding of a new UCSF-led analysis of quality of ... first-ever study focusing solely on staffing and quality at the ... in advance of print publication in Health Services ...
... more gray matter you have in the decision-making, thought-processing part ... and consequences. That may seem like an obvious conclusion, but ... Brookhaven National Laboratory is the first to show this link ... impairment of both structure and function in people addicted to ...
... HealthDay Reporter , TUESDAY, Nov. 29 (HealthDay News) -- Frequent ... brain damage leading to subtle but serious declines in thinking ... study, researchers used an advanced MRI technique to analyze changes ... who headed balls 436 times a year on average. Players ...
... , TUESDAY, Nov. 29 (HealthDay News) -- ,Creative ... are less creative, perhaps because being an original thinker ... to a new study. Harvard and Duke University ... would cheat in situations where they could justify their ...
... A groundbreaking new study shows that laws legalizing ... drop in traffic deaths and a five percent reduction ... legalization of medical marijuana reduces traffic fatalities through reducing ... of economics at the University of Colorado Denver who ...
Cached Medicine News:Health News:The implications of disease coexistence 2Health News:Low staffing and poor quality of care at nation's for-profit nursing homes 2Health News:Low staffing and poor quality of care at nation's for-profit nursing homes 3Health News:Gray matter in brain's control center linked to ability to process reward 2Health News:Gray matter in brain's control center linked to ability to process reward 3Health News:Could Soccer 'Headers' Cause Brain Injury? 2Health News:Could Soccer 'Headers' Cause Brain Injury? 3Health News:Creative Minds More Prone to Cheating 2Health News:Study shows medical marijuana laws reduce traffic deaths 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: